RESUMO
En la última década se ha producido un incremento sustancial en el conocimiento de las bases genéticas de las cardiomiopatías, en consideración a lo cual las Sociedades Americanas y Europea de Cardiología, han propuesto una nueva clasificación con el fin de incluir tales aspectos, Aunque se carece de datos precisos, aproximadamente el 30% de los pacientes con miocardiopatías referidos para pruebas genéticas presentan una variante genética patogénica. En la herencia de la miocardiopatía dilatada familiar, la modalidad predominante es la autosómica dominante, siendo mucho menos frecuentes las ligadas al cromosoma X, la herencia autosómica recesiva y la mitocondrial. A su vez, pruebas provenientes de ensayos clínicos y experimentales indican que la infección, la inflamación y el sistema inmunológico están de alguna manera interrelacionados en los mecanismos patogénicos implicados en la miocardiopatía dilatada, No hay duda que en un futuro próximo las mejoras en la secuenciación de genes y el mayor conocimiento de la patogenia influirán decididamente en el diagnóstico, evaluación y tratamiento de esta entidad.
In the last time, a substantial increase in the knowledge of the genetic basis of cardiomyopathy has occurred. Therefore in the last decade the American Heart Association, the American College of Cardiology and the European Society of Cardiology have proposed a new revision of the classification of cardiomyopathies in order to include the genetic basis on the etiology, Although precise data are lacking, approximately 30% of patients currently referred for clinical genetic testing will be found to have a pathogenic genetic variant. The predominant mode of inheritance for familial dilated cardiomyopathy is autosomal dominant, with X linked autosomal recessive and mitochondrial inheritance being less frequent. Evidence from experimental and clinical trials indicates that infection, inflammation and the immune system are in some way interrelated on the pathogenic mechanisms involved in the dilated cardiomyopathy, There is no doubt that in the future, improvements in sequencing genes and insight into pathogenesis will influence the diagnosis, evaluation and management of familial dilated cardiomyopathy.
Assuntos
Humanos , Cardiomiopatia Dilatada/genética , Cardiomiopatia Dilatada/imunologia , Cardiomiopatia Dilatada/microbiologia , Cardiomiopatia Dilatada/classificação , Cardiomiopatia Dilatada/parasitologia , InflamaçãoRESUMO
Chagasic cardiomyopathy is a common disease in Latin America, however similar clinical pictures exist that can be confused with this, as they give negative results to the tests that detects T. cruzi, like non Chagasic rural endemic chronic cardiopathy, highly common in Venezuela. Using histopathology techniques, "idiopathic cardiomyopathy" is frequently found as the cause of death when the etiology of this disease is not known. This paper presents the case of a man of 26-years-old who died of dilated cardiomyopathy secondary to leptospirosis. Clinically, in addition to the cardiac failure, jaundice, hyperbilirubinemia, transaminases increase, proteinuria and hematuria were present. Initially it was suspected Chagasic cardiomyopathy but the epidemiologic background and the parasitologic and serologic tests for T. cruzi gave negative results. The dark field microscopy videorecording of blood and urine samples, argentic impregnation and immunohistochemistry tests as well as haemoculture in EMJH medium were positive for L. interrogans serovar Pomona. Postmortem we confirmed the presence of leptospira in different tissues through of histopathology, argentic impregnation, indirect immunofluorescence and immunohistochemistry.
Assuntos
Cardiomiopatia Dilatada/microbiologia , Leptospirose/complicações , Adulto , Evolução Fatal , Humanos , Masculino , México , Índice de Gravidade de DoençaRESUMO
OBJECTIVE: To study atheromas, Mycoplasma pneumoniae (M. pneumoniae), and Chlamydia pneumoniae (C. pneumoniae). METHODS: C. pneumoniae was studied with immunohistochemistry and M. pneumoniae with in situ hybridization (ISH), in segments of coronary arteries (SCA) as follows: group A - thrombosed ruptured plaques (TRP) of 23 patients who died due to acute myocardial infarction (AMI); group B - 23 nonruptured plaques (NRP) of group A patients; group C - NRP of 11 coronary patients who did not die due to AMI; and group D - 11 SCA from patients with dilated cardiomyopathy or Chagas' disease without atherosclerosis. RESULTS: The mean number of C. pneumoniae+ cells/400x in groups A, B, C, and D was, respectively, 3.3 +/- 3.6; 1.0 +/- 1.3; 1.2 +/- 2.4; and 0.4 +/- 0.3; and the percentage of M. pneumoniae area was, respectively, 3.9 +/- 3.5; 1.5 +/- 1.6; 0.9 +/- 0.9; and 0.4 +/- 0.2. More M. pneumoniae and C. pneumoniae were found in of group A than in group B (P<0.01). Good correlation was seen between the area of the vessel and the M. pneumoniae area in the plaque (r = 0.46; P=0.001) and between C. pneumoniae+ cells and CD4+ T lymphocytes (r = 0.42; P<0.01). The number of C. pneumoniae+ cells correlated with CD20+ B cells (r=0.48; P<0.01). CONCLUSION: M. pneumoniae and C. pneumoniae are more frequently found in TRP correlate with the intensity of the inflammation and diameter of the vessel (positive remodeling).